Stock listing
A403RK Stock Price, News, Filings & Events — Agenus Inc.
Selected listing: A403RK · LS · EUR · DE
This page tracks Agenus Inc.'s A403RK:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A403RK:LS. A403RK:LS is the stock-level entry point for investors researching Agenus Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A403RK:LS
- Asset type
- Stock
- Market cap
- $312.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LS
- Currency
- EUR
Agenus Inc. A403RK:LS stock context
This page tracks Agenus Inc.'s A403RK:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A403RK:LS. A403RK:LS is the stock-level entry point for investors researching Agenus Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Agenus Inc.
Agenus to Present Three-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
September 10, 2026
Agenus to Participate in Upcoming September Investor Conferences
August 31, 2026
Agenus Announces Peer-Reviewed Publication Linking BOT+BAL’s Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-...
August 28, 2026
Agenus Announces Updated NEST Phase 2 Publication Reporting Deep Pathologic Responses and No Observed Recurrences with Neoadjuvant BOT+BA...
August 26, 2026
Agenus Reports Second Quarter 2026 Results and Advances Phase 3 ROBBIN Trial of BOT+BAL in Neoadjuvant MSS Colon Cancer
August 6, 2026
Agenus Inc. earnings calls
Agenus Inc. (AGEN) Q2 2025 Earnings Call
August 27, 2025 · Replay with transcript and chapters
Agenus Inc. (AGEN) Q4 2024 Earnings Call
March 11, 2025 · Replay with transcript and chapters
Agenus Inc. (AGEN) Q3 2024 Earnings Call
November 12, 2024 · Replay with transcript and chapters
Agenus Inc. (AGEN) Q1 2024 Earnings Call
May 7, 2024 · Replay with transcript and chapters
Agenus Inc. (AGEN) Q4 2023 Earnings Call
March 14, 2024 · Replay with transcript and chapters
Agenus Inc. (AGEN) Q3 2023 Earnings Call
November 7, 2023 · Replay with transcript and chapters
Research Agenus Inc.
Agenus Inc. investor report
Review AI stock analysis and investor report context for A403RK:LS.
Agenus Inc. company profile
View the public company page for Agenus Inc. on 6ix.
Agenus Inc. news
Read company news and market updates connected to Agenus Inc..
Agenus Inc. investor events
Find investor webinars, events, and replay context for Agenus Inc..
Alternate listings
AGEN:NASDAQ
US · USD
Alternate listing for Agenus Inc.; the primary context on this page is A403RK:LS.
A403RK:LSX
DE · EUR
Alternate listing for Agenus Inc.; the primary context on this page is A403RK:LS.
AJ8:GETTEX
DE · EUR
Alternate listing for Agenus Inc.; the primary context on this page is A403RK:LS.
AGEN:BX
CH · CHF
Alternate listing for Agenus Inc.; the primary context on this page is A403RK:LS.
AGEN:BOATS
US · USD
Alternate listing for Agenus Inc.; the primary context on this page is A403RK:LS.
AJ8:DUS
DE · EUR
Alternate listing for Agenus Inc.; the primary context on this page is A403RK:LS.
AJ8:FWB
DE · EUR
Alternate listing for Agenus Inc.; the primary context on this page is A403RK:LS.
AJ8:MUN
DE · EUR
Alternate listing for Agenus Inc.; the primary context on this page is A403RK:LS.
AJ8:TRADEGATE
DE · EUR
Alternate listing for Agenus Inc.; the primary context on this page is A403RK:LS.